Genfarma Strengthens Its Scientific Presence At The 14Th Annual Cancer Prevention And Control Scientific Conference

GENFARMA STRENGTHENING ITS SCIENTIFIC PRESENCE AT THE 14TH ANNUAL CANCER PREVENTION AND CONTROL SCIENTIFIC CONFERENCE

Over two days, 20–21 August 2026, at Hue Central Hospital, Genfarma Joint Stock Company participated in the 14th Annual Scientific Conference on Cancer Prevention and Control and Multidisciplinary Cancer Treatment Training Program as a Bronze Sponsor. This event was one of Genfarma’s key activities aimed at strengthening brand presence, fostering professional connections, and promoting scientific values in oncology.

The conference brought together approximately 700 delegates, including representatives from the Vietnam Cancer Association, the Ministry of Health, the leadership of Hue City, the University of Medicine and Pharmacy, Hue University, Hue Central Hospital, as well as leading experts and healthcare professionals from across the country. Featuring a series of in-depth scientific sessions, the event served as an important forum for updating advances in cancer management and treatment, while promoting professional networking and the exchange of expertise among specialists and healthcare institutions.
 

A COMPREHENSIVE PRESENCE IN BRANDING AND SCIENCE

Strengthening Genfarma’s Scientific Presence in Head and Neck Oncology

A key professional highlight of Genfarma’s activities at the conference was a scientific presentation delivered during Session D3 – Head and Neck Cancer on 21 August 2026.

Representing Genfarma, MSc., MD. Ngo Minh Thu presented the topic:
“The Latest Updates on Nimotuzumab in the Treatment of Head and Neck Cancer”

The presentation focused on updated scientific data on nimotuzumab in the treatment of head and neck cancer, providing participating physicians with additional professional perspectives. This activity contributed to strengthening Genfarma’s scientific presence and demonstrated the company’s commitment to supporting the oncology community through practical and valuable medical education and knowledge-update initiatives.


Strengthening Brand Awareness Through Professional Engagement

Alongside the scientific presentation, the Genfarma booth attracted interest and interaction from physicians and delegates attending the conference.

Through scientific materials, brochures, biotechnology videos, and interactive activities at the booth, Genfarma had the opportunity to engage directly with healthcare professionals, introduce its development strategy for high-tech pharmaceuticals and scientific information related to CIMAher® (nimotuzumab), while also gaining practical insights into the information needs and perspectives of physicians working in oncology.

Genfarma’s participation in the 14th Annual Scientific Conference on Cancer Prevention and Control reflects the company’s consistent direction: placing science at the core, strengthening connections with experts, and gradually establishing its position in the high-tech pharmaceutical sector. Going forward, Genfarma will continue to invest in scientific knowledge-update activities, professional exchange, and medical collaboration, thereby contributing to bringing advances in cancer treatment closer to clinical practice in Vietnam.

The information provided in this article is intended for communication and scientific activity updates only and does not replace advice or treatment recommendations from healthcare professionals.